Soft contact lenses do not influence IOP measurements

Article

Silicone hydrogel soft contact lenses do not significantly affect IOP measurements with non-contact tonometry (NCT).

Silicone hydrogel soft contact lenses do not significantly affect IOP measurements with non-contact tonometry (NCT), claims a study in the journal Eye.

The investigation, led by Dr P.G. Firat, Deparment of Ophthalmology, Turgut Ozal Medical Centre, Inonu University, Malatya, Turkey, included 40 eyes of 40 patients. The IOP values of each patient were gathered using NCT in patients with and without contact lenses - group 1 and 2, respectively. The remaining patients were measured with Pascal dynamic contour tonometry (DCT) with and without contact lenses - group 3 and 4, respectively. The last group consisted of patients measured by Goldmann applanation tonometry (GAT) without contact lens.

Group 1 demonstrated a mean IOP value of 14.55±2.95 mmHg, compared to 13.92±2.58 mmHg in group 2. Mean IOP values for group 3 and 4 were 16.26±2.33 mmHg and 15.19±2.40 mmHg, respectively.

A statistically significant difference was found between groups 3 and 4. It was also found that mean IOP value in group 5 was 12.97±2.65 mmHg, revealing that IOP values measured with DCT produced statistically significantly different results than IOP values measured with NCT and GAT.

IOP values measured with NCT were significantly higher than those measured with GAT. Wearing silicone hydrogel soft contact lenses can affect IOP values measured with DCT.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.